Rep. Tom Kean Jr. (R-NJ) returned to Capitol Hill on Tuesday, June 30, 2024, and announced he had been diagnosed with depression.
The disclosure follows a prolonged and unexplained absence from Washington, D.C., that raised questions about the representative's health and whereabouts. By addressing the issue on the House floor, Kean provides a public explanation for the gap in his legislative duties.
Kean said his diagnosis of severe depression required a long-term hospital stay [1]. This medical necessity led to a hiatus from Congress that lasted nearly four months [2]. Some reports specify this period as more than 100 days [3].
The absence resulted in significant legislative inactivity for the New Jersey representative. Kean missed more than 140 votes since March 5 [4].
The announcement took place on the House floor, marking his first formal appearance back in the chamber since the onset of his illness [1]. He did not provide specific details regarding his treatment beyond the mention of the hospital stay [2].
Kean's return comes after several weeks of speculation regarding his status in the House. The representative's decision to share his diagnosis publicly aligns with a broader trend of public officials discussing mental health struggles to reduce stigma, a move that often accompanies a return to public service after a medical leave.
“Rep. Tom Kean Jr. (R-NJ) returned to Capitol Hill on Tuesday, June 30, 2024, and announced he had been diagnosed with depression.”
The public nature of this disclosure highlights the increasing intersection of mental health and governance. By attributing a significant voting gap to a clinical diagnosis, Kean attempts to mitigate political criticism regarding his absence while emphasizing the severity of the condition. This may set a precedent for how other members of Congress handle medical leaves related to mental health.
